Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years (Q42277120)

19 October 2017

Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years (English)

1 reference

19 October 2017

0 references

vertical transmission

1 reference

M Abrahamowicz

5

0 references

author name string

M Wallon

1

1 reference

19 October 2017

F Peyron

2

1 reference

19 October 2017

C Cornu

3

1 reference

19 October 2017

S Vinault

4

1 reference

19 October 2017

C Bonithon Kopp

6

1 reference

19 October 2017

C Binquet

7

1 reference

19 October 2017

language of work or name

English

0 references

publication date

29 January 2013

1 reference

Clinical Infectious Diseases

19 October 2017

1 reference

19 October 2017

56

1 reference

19 October 2017

1223-1231

1 reference

19 October 2017

9

1 reference

Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants.

19 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Long-term ocular prognosis in 327 children with congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Congenital toxoplasmosis. A prospective study of 378 pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

In utero and at birth diagnosis of congenital toxoplasmosis: use of likelihood ratios for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Teratogenicity of high vitamin A intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Statistical data analysis in the computer age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Why prevent, diagnose and treat congenital toxoplasmosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Editorial Commentary: High Burden of Congenital Toxoplasmosis in the United States: The Strain Hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

Toxoplasmosis among pregnant women in France: Risk factors and change of prevalence between 1995 and 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT032

21 January 2018

Identifiers

DOI

10.1093/CID/CIT032

1 reference

19 October 2017

1 reference